Abstract:Circulation: Genomic and Precision Medicine, Ahead of Print. BACKGROUND:Interpretation of variants of uncertain significance (VUSs) remains a challenge in the care of patients with inherited cardiovascular diseases (CVDs); 56% of variants within CVD risk genes are VUS, and machine learning algorithms trained upon large data resources can stratify VUS into higher versus lower probability of contributing to a CVD phenotype.METHODS:We used ClinVar pathogenic/likely pathogenic and benign/likely benign variants from 47 CVD genes to build a predictive model of variant pathogenicity utilizing measures of evolutionary constraint, deleteriousness, splicogenicity, local pathogenicity, cardiac-specific expression, and population allele frequency. Performance was validated using variants for which the ClinVar pathogenicity assignment changed. Functional validation was assessed using prior studies in >900 identified VUS. The model utility was demonstrated using the Catheterization Genetics cohort.RESULTS:We identified a top-ranked model that accurately prioritized variants for which ClinVar clinical significance had changed (n=663; precision-recall area under the curve, 0.97) and performed well compared with conventional in silico methods. This model (CVD pathogenicity predictor) also had high accuracy in prioritizing VUS with functional effects in vivo (precision-recall area under the curve, 0.58). In Catheterization Genetics, there was a greater burden of higher CVD pathogenicity predictor scored VUS in individuals with dilated cardiomyopathy compared with controls (P=8.2×10−15). Of individuals in Catheterization Genetics who harbored highly ranked CVD pathogenicity predictor VUS meeting clinical pathogenicity criteria, 27.6% had clinical evidence of disease. Variant prioritization using this model increased genetic diagnosis in Catheterization Genetics participants with a known clinical diagnosis of hypertrophic cardiomyopathy (7.8%–27.2%).CONCLUSIONS:We present a cardiac-specific model for prioritizing variants underlying CVD syndromes with high performance in discriminating the pathogenicity of VUS in CVD genes. Variant review and phenotyping of individuals carrying VUS of pathogenic interest support the clinical utility of this model. This model could also have utility in filtering variants as part of large-scale genomic sequencing studies.

An platform to identify pathogenic loci

Towards Prediction and Prioritization of Disease Genes by the Modularity of Human Phenome-Genome Assembled Network.

Towards Identification of Human Disease Phenotype-Genotype Association via a Network-Module Based Method

A Robust Phenotype-Driven Likelihood Ratio Analysis Approach Assisting Interpretable Clinical Diagnosis of Rare Diseases.

PROTEORIZER: A holistic approach to untangle functional consequences of variants of unknown significance.

Human and mouse essentiality screens as a resource for disease gene discovery

Identification Of Sequence Variants In Genetic Disease-Causing Genes Using Targeted Next-Generation Sequencing

Refined preferences of prioritizers improve intelligent diagnosis for Mendelian diseases

VarPPUD: Variant post prioritization developed for undiagnosed genetic disorders

PERCH: A Unified Framework for Disease Gene Prioritization

Pinpointing Disease Genes Through Phenomic and Genomic Data Fusion

Cardiovascular Disease Pathogenicity Predictor (CVD-PP): A Tissue-Specific In Silico Tool for Discriminating Pathogenicity of Variants of Unknown Significance in Cardiovascular Disease Genes

PreMedKB: an Integrated Precision Medicine Knowledgebase for Interpreting Relationships Between Diseases, Genes, Variants and Drugs

Uncover Disease Genes by Maximizing Information Flow in the Phenome-Interactome Network.

Evaluation of phenotype-driven gene prioritization methods for Mendelian diseases

High Throughput PRIME Editing Screens Identify Functional DNA Variants in the Human Genome

CRISPR single base editing, neuronal disease modelling and functional genomics for genetic variant analysis: pipeline validation using Kleefstra syndrome EHMT1 haploinsufficiency

Predicting human disease mutations and identifying drug targets from mouse gene knockout phenotyping campaigns

Constructing Human Phenome-Interactome Networks for the Prioritization of Candidate Genes

Regsnps: a Strategy for Prioritizing Regulatory Single Nucleotide Substitutions.